Hepatology
Gastrointestinal and hepatic diseases impose a high burden on our community we serve this area with a list of our products.
JAVIDACLA®
Daclatasvir dihydrochloride 65.92 mg
Javidacla is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
More details
Javidacla is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Each film-coated tablet contains daclatasvir dihydrochloride 65.92 mg equivalent to 60 mg daclatasvir.
Javidacla is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
The recommended dose of JAVIDACLA is 60 mg once daily. JAVIDACLA must be administered in combination with other agents
Store at temperature not exceeding 30 °C, in a dry place.
Related Products
